133 related articles for article (PubMed ID: 27893713)
1. Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer.
Xiao T; Zhu JJ; Huang S; Peng C; He S; Du J; Hong R; Chen X; Bode AM; Jiang W; Dong Z; Zheng D
Oncogene; 2017 May; 36(20):2835-2845. PubMed ID: 27893713
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation.
Yao K; Cho YY; Bergen HR; Madden BJ; Choi BY; Ma WY; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(18):8725-35. PubMed ID: 17875713
[TBL] [Abstract][Full Text] [Related]
3. Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells.
Ouyang W; Hu Y; Li J; Ding M; Lu Y; Zhang D; Yan Y; Song L; Qu Q; Desai D; Amin S; Huang C
Carcinogenesis; 2007 Oct; 28(10):2218-26. PubMed ID: 17522069
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.
Zheng D; Cho YY; Lau AT; Zhang J; Ma WY; Bode AM; Dong Z
Cancer Res; 2008 Sep; 68(18):7650-60. PubMed ID: 18794154
[TBL] [Abstract][Full Text] [Related]
5. NFAT3 is required for EGF-induced COX-2 transcription, but neither iNOS transcription nor cell transformation in Cl 41 cells.
Li J; Lu H; Huang C
Mol Cell Biochem; 2006 Sep; 289(1-2):73-82. PubMed ID: 16718377
[TBL] [Abstract][Full Text] [Related]
6. NFAT3 is specifically required for TNF-alpha-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells.
Yan Y; Li J; Ouyang W; Ma Q; Hu Y; Zhang D; Ding J; Qu Q; Subbaramaiah K; Huang C
J Cell Sci; 2006 Jul; 119(Pt 14):2985-94. PubMed ID: 16803872
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of NFAT3 Due to Lack of T-Box Transcription Factor TBX5 Is Crucial for Cytokine Expression in T Cells.
Kaminuma O; Kitamura N; Nishito Y; Nemoto S; Tatsumi H; Mori A; Hiroi T
J Immunol; 2018 Jan; 200(1):92-100. PubMed ID: 29180489
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of NFAT3 blocked TPA-induced COX-2 and iNOS expression, and enhanced cell transformation in Cl41 cells.
Li J; Song L; Zhang D; Wei L; Huang C
J Cell Biochem; 2006 Nov; 99(4):1010-20. PubMed ID: 16475165
[TBL] [Abstract][Full Text] [Related]
9. p85α mediates NFAT3-dependent VEGF induction in the cellular UVB response.
Dong W; Li Y; Li X; Hu M; Aodengqimuge ; Sun L; Guo N; Yuan S; Song L
J Cell Sci; 2013 Mar; 126(Pt 6):1317-22. PubMed ID: 23390317
[TBL] [Abstract][Full Text] [Related]
10. Repression of NFAT3 transcriptional activity by estrogen receptors.
Qin X; Wang XH; Yang ZH; Ding LH; Xu XJ; Cheng L; Niu C; Sun HW; Zhang H; Ye QN
Cell Mol Life Sci; 2008 Sep; 65(17):2752-62. PubMed ID: 18668201
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus and ascomycin inhibit melanoma cell growth, migration and invasion via targeting nuclear factor of activated T-cell 3.
Xiao T; Chen W; Wang S; Huang S; Chiang C; Zou Y; Zhao Y; Zheng D
Melanoma Res; 2020 Aug; 30(4):325-335. PubMed ID: 32301802
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
Braun K; Hölzl G; Soucek T; Geisen C; Möröy T; Hengstschläger M
Oncogene; 1998 Oct; 17(17):2259-69. PubMed ID: 9811456
[TBL] [Abstract][Full Text] [Related]
13. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.
Zhang Z; Huang A; Zhang A; Zhou C
Biomed Pharmacother; 2017 Jul; 91():788-795. PubMed ID: 28501005
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase-3-mediated c-Jun phosphorylation at Ser63 and Ser73 enhances cell transformation.
Cho YY; Tang F; Yao K; Lu C; Zhu F; Zheng D; Pugliese A; Bode AM; Dong Z
Cancer Res; 2009 Jan; 69(1):272-81. PubMed ID: 19118012
[TBL] [Abstract][Full Text] [Related]
15. Tissue type-specific modulation of ER transcriptional activity by NFAT3.
Zhang H; Wang X; Li J; Zhu J; Xie X; Yuan B; Yang Z; Zeng M; Jiang Z; Li J; Huang C; Ye Q
Biochem Biophys Res Commun; 2007 Feb; 353(3):576-81. PubMed ID: 17194453
[TBL] [Abstract][Full Text] [Related]
16. CDK3 is a major target of miR-150 in cell proliferation and anti-cancer effect.
Wang L; Xi Y; Sun C; Zhang F; Jiang H; He Q; Li D
Exp Mol Pathol; 2017 Apr; 102(2):181-190. PubMed ID: 28108217
[TBL] [Abstract][Full Text] [Related]
17. Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells.
Wang Q; Li WL; You P; Su J; Zhu MH; Xie DF; Zhu HY; He ZY; Li JX; Ding XY; Wang X; Hu YP
J Cell Biochem; 2009 Jan; 106(1):16-24. PubMed ID: 19021148
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the paxillin pathway in JB6 Cl41 cell transformation.
Tatsumi Y; Cho YY; He Z; Mizuno H; Seok Choi H; Bode AM; Dong Z
Cancer Res; 2006 Jun; 66(11):5968-74. PubMed ID: 16740738
[TBL] [Abstract][Full Text] [Related]
19. NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.
Fougère M; Gaudineau B; Barbier J; Guaddachi F; Feugeas JP; Auboeuf D; Jauliac S
Oncogene; 2010 Apr; 29(15):2292-301. PubMed ID: 20101218
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
Kawahara T; Kashiwagi E; Li Y; Zheng Y; Miyamoto Y; Netto GJ; Ishiguro H; Miyamoto H
Mol Carcinog; 2016 Feb; 55(2):161-9. PubMed ID: 25594762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
